Table 1.

Transcripts with at least 3-fold higher levels in cells treated for 24 hours with cRA alone relative to untreated cells

(A) SKRC06 treated with cRA: transcripts changed by at least 3 fold
NCBI ID	Gene	Fold change + cRA/con	p value	Description
NM 003670	bhlbh2	3.8	0.000299	Basic heli-loop-helix domain containing, class b, 2
NM 001795	cdh5	14.8	0.000193	Cadherin 5, type 2. VE-cadherin (vascular epithelium)
NM 001807	cel	3.8	1.48e-06	Carboxyl ester lipase
NM 000783	cyp26a1	40.1	0.000198	Cytochrome p450, family 26, subfamily a, polypeptide 1
NM 019885	cyp26b1	118.6	4.13e-06	Cytochrome p450, family 26, subfamily b, polypeptide 1
NM 001465	fyb	3.6	0.00133	Fyn binding protein
NM 004751	gcnt3	4.8	0.000245	Glucosaminyl transferase, mucin-type
NM 006819	hop	0.236	0.00284	Homeodomain-only protein
NM 000598	igfbp3	3.5	0.0294	Insulin-like growth factor binding protein 3
NM 000422	krt17	0.2	0.000306	Keratin 17
NM 005564	lcn2	4.3	0.000186	Lipocalin 2 (oncogene 24p3)
NM 000582	spp1	16.9	0.00376	Secreted phosphoprotein 1
NM 005416	sprr3	0.331	0.000193	Small proline rich protein 1b
NM 001038	scnn1a	4.4	0.000245	Sodium channel, nonvoltage-gated 1 alpha
NM 003246	thbs1	0.288	0.0403	Thrombospondin 1
NM 014428	tjp3	3.4	0.0429	Tight junction protein 3 (zona occuldens)
NM 006074	trim22	3.5	0.00425	Tripartite motif-containing 22
NM 007028	trim31	52.8	8.64e-07	Tripartite motif-containing 31
NM 003810	tnfsf10	4.2	0.0138	Tumor necrosis factor (ligand) superfamily, member 10

(B) SKRC39 treated with cRA: transcripts changed by at least 3 fold
NCBI ID	Gene	Fold change	p value	Description
NM004753	Dhrs3	3.3	0.00686	Dehydrogenase reductase
NM005564	Lcn2	3.1	4.26e-5	Lipocalin 3 (oncogene 24p3)

(A) Transcripts for SKRC06 are listed in alphabetical order. The fold-change, p value and gene description are shown. (B) Transcripts for SKRC39 are listed in alphabetical order. The fold-change, p value and gene description are shown.